From molecule
to market:
Ensuring safety
every step of the way.

03 / ABOUT CEO

Dr. Joan D’souza

Dr. Joan D’souza is a senior pharmacovigilance and regulatory affairs professional with extensive global experience across the US and Europe. Currently, serving as a Local Qualified Person for Pharmacovigilance (LQPPV), Fachtechnisch verantwortliche Person (FvP) (Responsible Person), Certified Lead GVP/ GCP Auditor, and Regulatory Affairs (LCPRA) in Switzerland, Germany, and Liechtenstein—as well as Deputy LQPPV in the UK and Ireland and Pharmacovigilance Physician—she oversees comprehensive safety surveillance and regulatory compliance across the entire product lifecycle, from market release decision to submission.

With a rare combination of qualifications—a medical degree, licensure as a U.S. attorney, a Master’s in Pharmacovigilance, an advanced diploma in pharmacovigilance software training, and an ongoing PhD studies in Pharmaceuticals —Joan brings a uniquely multidisciplinary perspective to drug safety and GxP quality assurance. Her work involves direct engagement with health authorities to ensure clinical and scientific compliance across clinical development and post-marketing activities.

As the founder of JD Pharma Services, a one-stop solution provider for pharmaceutical needs, and a moderator of the pharmacovigilance, regulatory affairs, and Drug Device Combinations Working Groups at Zug Pharma Group, as well as former President of the ISoP Swiss and Austria Chapter, Joan remains a driving force in safety, clinical development, regulatory intelligence, vendor oversight, and pharmacovigilance training. Fluent in English and German, she is dedicated to advancing patient safety through operational excellence and regulatory integrity.